S R Thompson|S E Humphries - JoVE Visualize

Showing results (251-260 of 334) with videos related to

Pageof 34

Sort By:

Atherosclerosis|January 28, 2006

Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitusP T E Wootton, J W Stephens, S J Hurel, et al.

Thrombosis and Haemostasis|February 23, 2002

The effect of fibrinogen genotype on fibrinogen levels after strenuous physical exerciseD J Brull, S Dhamrait, R Moulding, et al.

Annals of Clinical Biochemistry|October 20, 2009

Development of a high-resolution melting method for mutation detection in familial hypercholesterolaemia patientsR A Whittall, M Scartezini, Kawah Li, et al.

Atherosclerosis|May 12, 2004

The -344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy menJ R Payne, S S Dhamrait, I S Toor, et al.

Annals of Human Genetics|November 4, 2005

The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4P J Talmud, J W Stephens, E Hawe, et al.

American Journal of Epidemiology|October 8, 1999

Relations of plasma fibrinogen level in children to measures of obesity, the (G-455-->A) mutation in the beta-fibrinogen promoter gene, and family history of ischemic heart disease: the Columbia University BioMarkers StudyS Shea, C R Isasi, S Couch, et al.

Social Psychiatry and Psychiatric Epidemiology|July 16, 2005

APOE polymorphism, socioeconomic status and cognitive function in mid-life--the Whitehall II longitudinal studyJ H Zhao, E J Brunner, M Kumari, et al.

Human Genetics|January 1, 1984

Familial apolipoprotein CII deficiency: a preliminary analysis of the gene defect in two independent familiesS E Humphries, L Williams, O Myklebost, et al.

Atherosclerosis|August 12, 1998

The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography TrialS E Humphries, L A Luong, P J Talmud, et al.

Clinical Genetics|November 18, 2003

FH-Pyrgos: a novel mutation in the promoter (-45delT) of the low-density lipoprotein receptor gene associated with familial hypercholesterolemiaG V Z Dedoussis, C Pitsavos, D Kelberman, et al.

Pageof 34

Showing results (251-260 of 334) with videos related to

Sort By:

Pageof 34

Atherosclerosis|January 28, 2006

Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitusP T E Wootton, J W Stephens, S J Hurel, et al.

Thrombosis and Haemostasis|February 23, 2002

The effect of fibrinogen genotype on fibrinogen levels after strenuous physical exerciseD J Brull, S Dhamrait, R Moulding, et al.

Annals of Clinical Biochemistry|October 20, 2009

Development of a high-resolution melting method for mutation detection in familial hypercholesterolaemia patientsR A Whittall, M Scartezini, Kawah Li, et al.

Atherosclerosis|May 12, 2004

The -344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy menJ R Payne, S S Dhamrait, I S Toor, et al.

Annals of Human Genetics|November 4, 2005

The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4P J Talmud, J W Stephens, E Hawe, et al.

American Journal of Epidemiology|October 8, 1999

Relations of plasma fibrinogen level in children to measures of obesity, the (G-455-->A) mutation in the beta-fibrinogen promoter gene, and family history of ischemic heart disease: the Columbia University BioMarkers StudyS Shea, C R Isasi, S Couch, et al.

Social Psychiatry and Psychiatric Epidemiology|July 16, 2005

APOE polymorphism, socioeconomic status and cognitive function in mid-life--the Whitehall II longitudinal studyJ H Zhao, E J Brunner, M Kumari, et al.

Human Genetics|January 1, 1984

Familial apolipoprotein CII deficiency: a preliminary analysis of the gene defect in two independent familiesS E Humphries, L Williams, O Myklebost, et al.

Atherosclerosis|August 12, 1998

The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography TrialS E Humphries, L A Luong, P J Talmud, et al.

Clinical Genetics|November 18, 2003

FH-Pyrgos: a novel mutation in the promoter (-45delT) of the low-density lipoprotein receptor gene associated with familial hypercholesterolemiaG V Z Dedoussis, C Pitsavos, D Kelberman, et al.

Pageof 34